• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体信号赋予膀胱尿路上皮细胞癌克隆形成和迁移优势。

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.

机构信息

Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, the Netherlands.

出版信息

Mol Oncol. 2021 Jul;15(7):1882-1900. doi: 10.1002/1878-0261.12957. Epub 2021 May 22.

DOI:10.1002/1878-0261.12957
PMID:33797847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8253097/
Abstract

Bladder urothelial cell carcinoma (UCC) incidence is about three times higher in men compared with women. There are several indications for the involvement of hormonal factors in the aetiology of UCC. Here, we provide evidence of androgen signalling in UCC progression. Microarray and qPCR analysis revealed that the androgen receptor (AR) mRNA level is upregulated in a subset of UCC cases. In an AR-positive UCC-derived cell line model, UM-UC-3-AR, androgen treatment increased clonogenic capacity inducing the formation of big stem cell-like holoclones, while AR knockdown or treatment with the AR antagonist enzalutamide abrogated this clonogenic advantage. Additionally, blockage of AR signalling reduced the cell migration potential of androgen-stimulated UM-UC-3-AR cells. These phenotypic changes were accompanied by a rewiring of the transcriptome with almost 300 genes being differentially regulated by androgens, some of which correlated with AR expression in UCC patients in two independent data sets. Our results demonstrate that AR signals in UCC favouring the development of an aggressive phenotype and highlights its potential as a therapeutic target for bladder cancer.

摘要

膀胱癌尿路上皮细胞癌 (UCC) 的发病率男性比女性高约三倍。有几种迹象表明,荷尔蒙因素在 UCC 的发病机制中起作用。在这里,我们提供了雄激素信号在 UCC 进展中的证据。微阵列和 qPCR 分析显示,雄激素受体 (AR) mRNA 水平在一部分 UCC 病例中上调。在 AR 阳性的 UCC 衍生细胞系模型 UM-UC-3-AR 中,雄激素处理增加了集落形成能力,诱导形成大的干细胞样合胞体,而 AR 敲低或用 AR 拮抗剂恩杂鲁胺处理则消除了这种集落形成优势。此外,阻断 AR 信号降低了雄激素刺激的 UM-UC-3-AR 细胞的迁移能力。这些表型变化伴随着转录组的重布线,将近 300 个基因受到雄激素的差异调节,其中一些基因与两个独立数据集的 UCC 患者的 AR 表达相关。我们的研究结果表明,AR 在 UCC 中的信号有利于侵袭性表型的发展,并突出了其作为膀胱癌治疗靶点的潜力。

相似文献

1
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.雄激素受体信号赋予膀胱尿路上皮细胞癌克隆形成和迁移优势。
Mol Oncol. 2021 Jul;15(7):1882-1900. doi: 10.1002/1878-0261.12957. Epub 2021 May 22.
2
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.雄激素受体的条件性表达增加小鼠膀胱癌易感性。
PLoS One. 2016 Feb 10;11(2):e0148851. doi: 10.1371/journal.pone.0148851. eCollection 2016.
3
Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder.雄激素受体抑制剂联合顺铂治疗膀胱癌有效。
Urol Oncol. 2019 Jul;37(7):492-502. doi: 10.1016/j.urolonc.2019.03.008. Epub 2019 Apr 18.
4
Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.雄激素受体、5α还原酶1和5α还原酶2在膀胱尿路上皮癌中的表达及其与临床病理因素的关系。
Life Sci. 2017 Dec 1;190:15-20. doi: 10.1016/j.lfs.2017.09.029. Epub 2017 Sep 23.
5
Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.转录的超保守区 Uc.63+ 通过调节膀胱癌中的雄激素受体信号转导促进顺铂耐药性。
Oncol Rep. 2019 May;41(5):3111-3118. doi: 10.3892/or.2019.7039. Epub 2019 Feb 28.
6
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.雄激素受体共激活因子在膀胱尿路上皮癌中的表达及意义
Endocr Relat Cancer. 2009 Mar;16(1):123-37. doi: 10.1677/ERC-08-0124. Epub 2008 Oct 9.
7
Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.雄激素受体通过促进上皮-间质转化诱导膀胱癌进展。
Andrologia. 2014 Dec;46(10):1128-33. doi: 10.1111/and.12203. Epub 2013 Dec 16.
8
ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.ELK1在膀胱癌细胞中被雄激素上调,并促进肿瘤进展。
Oncotarget. 2015 Oct 6;6(30):29860-76. doi: 10.18632/oncotarget.5007.
9
Androgen activates β-catenin signaling in bladder cancer cells.雄激素激活膀胱癌细胞中的β-连环蛋白信号通路。
Endocr Relat Cancer. 2013 May 20;20(3):293-304. doi: 10.1530/ERC-12-0328. Print 2013 Jun.
10
Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.核因子-κB 通过与雄激素受体信号合作促进尿路上皮肿瘤发生和癌症进展。
Mol Cancer Ther. 2018 Jun;17(6):1303-1314. doi: 10.1158/1535-7163.MCT-17-0786. Epub 2018 Mar 28.

引用本文的文献

1
Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysis.非那雄胺对调节膀胱癌风险及临床结局的影响:一项全面荟萃分析的见解
Front Pharmacol. 2025 Jan 29;16:1471442. doi: 10.3389/fphar.2025.1471442. eCollection 2025.
2
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.《怪奇物语》:雄激素受体在肿瘤学中除前列腺癌以外的新角色和新机遇
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad071.
3
The androgen receptor in bladder cancer.

本文引用的文献

1
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.ZHX3 通过抑制 RGS2 促进膀胱癌的进展,是 TRIM21 的一种新型底物。
Cancer Sci. 2021 May;112(5):1758-1771. doi: 10.1111/cas.14810. Epub 2021 Mar 9.
2
SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.SH3RF3 通过激活 JNK 和上调 PTX3 促进乳腺癌干细胞样特性。
Nat Commun. 2020 May 19;11(1):2487. doi: 10.1038/s41467-020-16051-9.
3
Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
膀胱癌中的雄激素受体。
Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18.
4
Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.雄激素抑制疗法对膀胱癌风险和预后的影响:一项系统评价和荟萃分析。
Front Oncol. 2021 Dec 14;11:784627. doi: 10.3389/fonc.2021.784627. eCollection 2021.
5
Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity.尿路上皮膀胱癌的性别差异:自然杀伤淋巴细胞免疫的影响
J Clin Med. 2021 Nov 4;10(21):5163. doi: 10.3390/jcm10215163.
驱动扩增的 BCL6 抑制细胞静止是通过反式抑制 FOXO3 和膀胱尿路上皮癌中 FOXO3 的翻译后修饰来介导的。
Theranostics. 2020 Jan 1;10(2):707-724. doi: 10.7150/thno.39018. eCollection 2020.
4
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.TFCP2L1 的磷酸化由 CDK1 调控,这对于干细胞的多能性和膀胱癌的发生是必需的。
EMBO Mol Med. 2020 Jan 9;12(1):e10880. doi: 10.15252/emmm.201910880. Epub 2019 Nov 11.
5
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling.雄激素二氢睾酮 (DHT) 通过新鉴定的膜雄激素受体 (mAR-SLC39A9) 介导的 Gαi 蛋白/MAPK/MMP9 细胞内信号促进膀胱癌核 AR 阴性细胞侵袭。
Oncogene. 2020 Jan;39(3):574-586. doi: 10.1038/s41388-019-0964-6. Epub 2019 Sep 10.
6
PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.PLCε 通过 STAT3/LDHA 通路介导的糖酵解促进膀胱癌细胞增殖。
Oncol Rep. 2019 May;41(5):2844-2854. doi: 10.3892/or.2019.7056. Epub 2019 Mar 13.
7
Non-canonical AR activity facilitates endocrine resistance in breast cancer.非经典雄激素受体活性促进乳腺癌内分泌耐药。
Endocr Relat Cancer. 2019 Feb 1;26(2):251-264. doi: 10.1530/ERC-18-0333.
8
FKBP51 promotes migration and invasion of papillary thyroid carcinoma through NF-κB-dependent epithelial-to-mesenchymal transition.FKBP51通过依赖NF-κB的上皮-间质转化促进甲状腺乳头状癌的迁移和侵袭。
Oncol Lett. 2018 Dec;16(6):7020-7028. doi: 10.3892/ol.2018.9517. Epub 2018 Sep 27.
9
LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.LDH-A 通过激活肺腺癌中的上皮-间充质转化促进恶性行为。
Biosci Rep. 2019 Jan 15;39(1). doi: 10.1042/BSR20181476. Print 2019 Jan 31.
10
Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.长链非编码 RNA 神经母细胞瘤相关转录本 1 基因通过 miR-21/SOCS6 轴抑制膀胱癌的恶性细胞表型。
Cell Death Dis. 2018 Oct 11;9(10):1042. doi: 10.1038/s41419-018-1090-z.